...
首页> 外文期刊>Psychoneuroendocrinology: An International Journal >Thyroid function tests at delivery and risk for postpartum depressive symptoms
【24h】

Thyroid function tests at delivery and risk for postpartum depressive symptoms

机译:甲状腺功能检查在分娩时和产后抑郁症状的风险

获取原文
获取原文并翻译 | 示例
   

获取外文期刊封面封底 >>

       

摘要

Postpartum depression (PPD) is a common childbirth complication, which can have negative effects on both the newly delivered woman and her family. This condition is underdiagnosed and inadequately treated, while a biological diagnostic test is not yet available. Furthermore, postpartum thyroid dysfunction is common among new mothers, and some evidence point to an association between PPD and thyroid function disturbances. The aim of this study was to evaluate the possible association between serum levels of thyroid hormones at the time of delivery, and the later development of depressive symptoms, using data from a population based cohort of Swedish women. Blood samples were collected during delivery from 347 participating women, delivering at Uppsala University Hospital. The participating women filled in at least one of three structured questionnaires, containing the Edinburgh Postnatal Depression Scale (EPDS), at five days, six weeks and six months postpartum. A cut-off of 12 or more was applied on the EPDS, to identify cases of self-reported PPD and controls. Using a binary logistic regression model (adjusting for previous psychiatric contact, smoking during pregnancy, pre-pregnancy body mass index (BMI) and sleep), having a thyroid stimulating hormone (TSH) level over the clinical cut-off level of 4.0. mU/L was associated with increased risk for depressive symptoms at six months postpartum (OR 11.30, 95% CI 1.93-66.11). A ROC analysis revealed that the predictive variable (PV) had significant predictive ability for PPD at 6 months postpartum, given that the AUC was 0.764, and at a PV cut-off value of 6.33, the sensitivity and specificity were 76.2% and 69.4%, respectively. If these findings are replicated in future studies, they can have important clinical implications, since TSH determination is an inexpensive routine blood test, and its inclusion in a biological screening test for PPD involving other parameters would be tempting.
机译:产后抑郁症(PPD)是一种常见的分娩并发症,对新分娩的妇女及其家人均可能产生负面影响。这种情况诊断不足,治疗不充分,而生物学诊断测试尚不可用。此外,产后甲状腺功能异常在新妈妈中很常见,一些证据表明PPD与甲状腺功能障碍之间存在关联。这项研究的目的是使用来自瑞典女性人群的数据,评估分娩时甲状腺激素的血清水平与抑郁症状后来发展之间的可能联系。在分娩过程中,从乌普萨拉大学医院分娩的347名妇女中采集了血液样本。参与调查的妇女在产后5天,6周和6个月内至少填写了三种结构性问卷中的一种,其中包含爱丁堡产后抑郁量表(EPDS)。在EPDS上采用了12或更高的临界值,以识别自我报告的PPD和对照的病例。使用二进制logistic回归模型(针对先前的精神病接触,怀孕期间吸烟,怀孕前体重指数(BMI)和睡眠进行调整),其甲状腺刺激激素(TSH)水平超过临床临界值4.0。 mU / L与产后六个月出现抑郁症状的风险增加相关(OR 11.30,95%CI 1.93-66.11)。 ROC分析显示,预测变量(PV)对产后6个月的PPD具有显着的预测能力,考虑到AUC为0.764,PV截止值为6.33,敏感性和特异性分别为76.2%和69.4% , 分别。如果将这些发现在以后的研究中重复使用,则它们可能具有重要的临床意义,因为TSH测定是一种廉价的常规血液检查,并且将其包含在涉及其他参数的PPD生物学检查中非常诱人。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号